VIRVir Biotechnology, Inc.vs its industry peers
A metric-by-metric comparison of Vir Biotechnology, Inc. against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIREsta | $1.8B#8 | — | 1.8x#2 | 25.8x#9 | -7.6%#10 | 16.1%#6 | -699.2%#8 | -44.6%#8 | — | — | 117.7%#5 | — |
| RVMDW | $2.8B#1 | — | 1.1x#1 | — | — | -88.5%#12 | — | -43.4%#7 | — | — | 4197.3%#1 | — |
| BEAM | $2.4B#2 | — | 2.3x#4 | 17.2x#7 | 120.0%#3 | 78.8%#3 | -274.6%#7 | -7.5%#4 | -40.5%#3 | — | 9.3%#10 | — |
| BCRX | $2.1B#3 | — | — | 2.4x#2 | 94.1%#4 | 396.9%#1 | 39.0%#2 | — | — | — | 6.1%#11 | — |
| KOD | $2.1B#4 | — | 34.0x#11 | — | — | -30.5%#9 | — | -376.4%#11 | — | — | 253.0%#3 | — |
| VCEL | $2.0B#5 | 82.8x#4 | 5.5x#10 | 7.4x#4 | 16.5%#9 | 59.4%#4 | 4.0%#4 | 4.5%#2 | 4.0%#2 | 7#1 | 26.8%#8 | — |
| ADMA | $1.9B#6 | 12.3x#2 | 4.7x#9 | 3.8x#3 | 19.6%#7 | -25.7%#8 | 37.5%#3 | 36.0%#1 | 32.9%#1 | 5#2 | -43.8%#15 | — |
| COAG | $1.9B#7 | — | 4.1x#7 | — | — | — | — | 0.0%#3 | — | — | — | — |
| RXRX | $1.7B#9 | — | 1.9x#3 | 23.2x#8 | 26.9%#6 | -39.1%#11 | -867.9%#9 | -70.5%#10 | -175.2%#5 | — | -32.3%#14 | — |
| TSHA | $1.7B#10 | — | 4.3x#8 | 169.0x#10 | 17.3%#8 | -22.1%#7 | -1130.6%#10 | -28.1%#5 | — | — | 68.2%#7 | — |
| INBX | $1.6B#11 | — | — | 1205.0x#11 | 550.0%#1 | -108.3%#13 | -10386.5%#11 | — | — | — | 292.0%#2 | — |
| NVAX | $1.5B#12 | — | — | 1.4x#1 | 64.7%#5 | 334.8%#2 | 40.3%#1 | — | — | — | 14.4%#9 | — |
| MAZE | $1.3B#13 | — | 3.0x#5 | 8.0x#5 | — | -351.0%#14 | -85.3%#5 | -28.9%#6 | -49.4%#4 | — | 4.2%#12 | — |
| CGEM | $1.3B#14 | — | 3.2x#6 | — | -100.0%#11 | -31.2%#10 | — | -53.8%#9 | — | — | 224.1%#4 | — |
| VOR | $1.3B#15 | 0.1x#1 | — | — | — | -495.3%#15 | — | — | — | — | -29.8%#13 | — |
| MGTX | $1.2B#16 | 14.7x#3 | — | 15.1x#6 | 144.6%#2 | 22.7%#5 | -130.2%#6 | — | — | — | 74.1%#6 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice